clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Outreach Program Improves Colorectal Cancer Testing Rates
News & Features
New Method Shows Promise to Deliver Therapeutics Across the Blood-Brain Barrier
News & Features
BridgeBio’s Attruby Approved for Rare Heart Disease
Informatics
AMP Expo Chatter: Can AI Algorithms Be LDTs?
News & Features
Spatial Transcriptomics Offer New Insights into Alzheimer’s Disease
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Cognoa Wins FDA Class II Designation for AI-Based Autism Diagnostic
Cognoa
Molecular Dx
Cognoa Wins FDA Class II Designation for AI-Based Autism Diagnostic
February 21, 2018
0
Related Content
AMP Expo Chatter: Can AI Algorithms Be LDTs?
New Atlas of the Plasma Proteome Provides Important Insights into Health and Disease
Wearable Ultrasound Patch Offers Breakthrough in Continuous Blood Pressure Monitoring
At the Forefront of Molecular Pathology: The Latest Collaborations and Diagnostic Tools
Inside Precision Medicine
![Cognoa's artificial intelligence-based software platform for behavioral health conditions has received the FDA’s Class II diagnostic medical device designation for autism. [© ktsdesign/Fotolia]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1500.jpeg "Cognoa Wins FDA Class II Designation for AI-Based Autism Diagnostic")
